PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Anti-PP2Aα, 200 μl
Anti-Presenilin 2, 1 ml
Anti-Prox1, 200 µl
Anti-Synaptobrevin (VAMP), 500 μl
Anti-Synuclein-α/β, 130-140, 200 μl
Anti-Tau, 20-35, 500 μl
Anti-Tau, 95-108 (PHF), 100 μl
Anti-Tubulin β-3, Polymerized (TUBB3), 500 μl
Anti-TYRP1 (MEL-5), 1 ml
Anti-Ubiquitin, 64-76 (free/bound), 200 μl
Anti-α-Synuclein, 200 μl
Anti-β-Amyloid, 1-16, 1 ml
Anti-β-Amyloid, 1-16, 200 μl
Anti-β-Amyloid, 1-16, 500 μl
Anti-β-Amyloid, 17-24, 1 ml
Anti-β-Amyloid, 17-24, 200 μl